How does CRISPR-Cas9 differ from earlier recombinant DNA methods?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

CRISPR-Cas9 differs from earlier recombinant DNA and gene editing methods—such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs)—primarily in its mechanism of targeting and its overall efficiency.

  • Targeting Mechanism: Earlier technologies relied on complex, engineered fusion proteins to bind to specific DNA sequences. In contrast, CRISPR-Cas9 utilizes RNA-DNA binding. By designing a simple guide RNA sequence based on Watson-Crick base-pairing rules, researchers can direct the Cas9 nuclease to a precise location in the genome with greater ease and flexibility.12
  • Efficiency and Cost: While previous genetic engineering tools allowed for modifications, they were often complicated, costly, and limited in scope. CRISPR-Cas9 is recognized for being more efficient, reliable, and less expensive, enabling broader applications in research, agriculture, and medicine.12

The precision of CRISPR-Cas9 represents a significant leap in the ability to customize genetic makeup, though it also necessitates a strong commitment to ethical responsibility, particularly regarding the potential for permanent germ-line modifications in humans.12